Last reviewed · How we verify
NCT05300360
Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis
trial testing adenosine deaminase test in Pulmonary Alveolar Proteinosis in 15 participants. Status unknown.
16 September 2021
Quick facts
| Lead sponsor | TRPHARM |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 16 August 2021 |
| Primary completion | 16 September 2021 |
| Estimated completion | 16 August 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- adenosine deaminase test
Conditions studied
- Pulmonary Alveolar Proteinosis — all drugs for Pulmonary Alveolar Proteinosis →
Sponsor
TRPHARM — full company profile →
Who can join
Adults 18 to 70, any sex, with Pulmonary Alveolar Proteinosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study was designed as a prospective epidemiological screening study. Patients who have applied to the centers participating in the study and who have previously been clinically or pathologically diagnosed with PAP (Pulmonary alveolar proteinosis) will be included in the study. Up-to-date data will be collected from patients who have agreed to participate in the study, and a blood sample with DBS will be taken from patients. The blood taken will be subjected to analysis for ADA metabolites. For patients with a high metabolic test, the responsible researcher will advise on clarifying the diagnosis with a genetic test other than the study. In case of formation of new information for each patient, consultation will be provided by the responsible researcher. Thus, the prevalence of ADA enzyme deficiency disease will be evaluated in patients diagnosed with PAP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05300360
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of adenosine deaminase test
Trials testing the same drug.
- NCT05300334 — Investigation of ADA Enzyme Deficiency · unknown
Other TRPHARM trials
Trials by the same sponsor.
- NCT05300373 — Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E · unknown
- NCT05300347 — Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) · unknown
- NCT04113083 — An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease · terminated
- NCT05300334 — Investigation of ADA Enzyme Deficiency · unknown
- NCT03584893 — The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05300360 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TRPHARM
- Last refreshed: 29 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05300360.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing